Biolase (NASDAQ:BIOL) Given Daily News Sentiment Rating of 0.12
Biolase logo Press coverage about Biolase (NASDAQ:BIOL) has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicĀ …